In February 2017, Australia legalised the importing of cannabis for medicinal applications. People who suffer from chronic pain, epilepsy, and even some cancers may soon have access to what some say is a miracle worker. Investors already have access to some listed companies producing the goods.
Aunt Zelda is an offshoot of a Californian operation focused on cannabis research and medical trials. Stewart Washer is the Managing Director and explains the differences between the US and Australian markets. Full transcript Alan Kohler: Now, just tell a bit about the background of Zelda. It came out of the night at Zelda’s in the … Continue reading “Stewart Washer – Zelda Therapeutics”
Adam Blumenthal is a non-executive Director & Co-founder of cannabis company Creso Pharma. Creso is breeding the TCH out of the cannabis and planning on entering the veterinary supply market. Full transcript Alan Kohler: Now can you give us a bit of the background on Creso? It was IPOed last year. When did the company begin? Adam Blumenthal: Sure. … Continue reading “Adam Blumenthal – Creso Pharma”
Dr Elaine Darby is Managing Director of AusCann who are growing cannabis and supplying it to cannabis research company Zelda . Dr Darby explains the growing process and outlines some of its health benefits. Full transcript Alan: Now AusCann is a grower of cannabis. Is that correct? Have you got more than one crop? Elaine: Yeah. … Continue reading “Elaine Darby – AusCann”
Starting out a scientist with Johnson and Johnson, German Bianca Ogden is part of an elite group of female portfolio managers in successful Australian equity funds. Thriving in a male dominated environment, this Fund Manager is part of a small group of decision makers managing the sizeable investment at Platinum Asset Management. She may still find it hard to work the room at networking events but she knows her way around pharmaceutical investments. Bianca recommends beginner investors take their lead from a German nun.
The Constant Investor publication and related content is provided for general information purposes only and should not be considered personal advice. Anyone seeking to rely on content should seek their own legal, financial and taxation advice. Kohler & Company Pty Ltd, trading as The Constant Investor, is an AFSL Authorised Representative No. 1244896 of Melbourne Securities Corporation Ltd AFSL 428289.